These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25455487)

  • 1. Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors.
    Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; Lee J
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5473-7. PubMed ID: 25455487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors.
    Kim J; Kwon J; Lee D; Jo S; Park DS; Choi J; Park E; Hwang JY; Ko Y; Choi I; Ju MK; Ahn J; Kim J; Han SJ; Kim TH; Cechetto J; Nam J; Ahn S; Sommer P; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2013 Jan; 23(1):153-7. PubMed ID: 23206860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of substituted thieno[2,3-d]pyrimidine-2,4-dithiones and their S-glycoside analogues as potential antiviral and antibacterial agents.
    Hafez HN; Hussein HA; El-Gazzar AR
    Eur J Med Chem; 2010 Sep; 45(9):4026-34. PubMed ID: 20691339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives possessing diaryl semicarbazone scaffolds as potent antitumor agents.
    Liu Z; Wu S; Wang Y; Li R; Wang J; Wang L; Zhao Y; Gong P
    Eur J Med Chem; 2014 Nov; 87():782-93. PubMed ID: 25440879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended structure-activity study of thienopyrimidine-based EGFR inhibitors with evaluation of drug-like properties.
    Bugge S; Buene AF; Jurisch-Yaksi N; Moen IU; Skjønsfjell EM; Sundby E; Hoff BH
    Eur J Med Chem; 2016 Jan; 107():255-74. PubMed ID: 26599532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone-based inhibitors of Cyclin D1-CDK4: synthesis, biological evaluation, and structure-activity relationships.
    Horiuchi T; Chiba J; Uoto K; Soga T
    Bioorg Med Chem Lett; 2009 Jan; 19(2):305-8. PubMed ID: 19091560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents.
    Liu Z; Wang Y; Lin H; Zuo D; Wang L; Zhao Y; Gong P
    Eur J Med Chem; 2014 Oct; 85():215-27. PubMed ID: 25086238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of pyrido-thieno-pyrimidines as potent and selective Cdc7 kinase inhibitors.
    Zhao C; Tovar C; Yin X; Xu Q; Todorov IT; Vassilev LT; Chen L
    Bioorg Med Chem Lett; 2009 Jan; 19(2):319-23. PubMed ID: 19071019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel c-Met kinase inhibitors bearing a thieno[2,3-d]pyrimidine or furo[2,3-d]pyrimidine scaffold.
    Zhao A; Gao X; Wang Y; Ai J; Wang Y; Chen Y; Geng M; Zhang A
    Bioorg Med Chem; 2011 Jul; 19(13):3906-18. PubMed ID: 21665484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
    Li X; Lu X; Chen W; Liu H; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2014 Oct; 22(19):5290-7. PubMed ID: 25150090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors.
    Naidu BN; Sorenson ME; Patel M; Ueda Y; Banville J; Beaulieu F; Bollini S; Dicker IB; Higley H; Lin Z; Pajor L; Parker DD; Terry BJ; Zheng M; Martel A; Meanwell NA; Krystal M; Walker MA
    Bioorg Med Chem Lett; 2015 Feb; 25(3):717-20. PubMed ID: 25529736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel thieno[2,3-d]pyrimidine-based FLT3 inhibitors as anti-leukemic agents.
    Yang JS; Park CH; Lee C; Kim H; Oh C; Choi Y; Kang JS; Yun J; Jeong JH; Kim MH; Han G
    Eur J Med Chem; 2014 Oct; 85():399-407. PubMed ID: 25108079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the in vitro antiviral activity of a series of new pyrimidine analogues on the replication of HIV and HCV.
    Jafar NN; Al-Masoudi NA; Baqir SJ; Leyssen P; Pannecouque C
    Antivir Chem Chemother; 2012 Sep; 23(3):103-12. PubMed ID: 23010622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 2: discovery of novel [1,2,4]Triazolo[1,5-a]pyrimidines using a structure-guided core-refining approach.
    Wang L; Tian Y; Chen W; Liu H; Zhan P; Li D; Liu H; De Clercq E; Pannecouque C; Liu X
    Eur J Med Chem; 2014 Oct; 85():293-303. PubMed ID: 25089812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2.
    Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM
    Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
    Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
    Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates.
    Islam F; Quadery TM
    Curr Drug Targets; 2021; 22(17):1944-1963. PubMed ID: 34042033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antimicrobial activity of new substituted thienopyrimidines, their tetrazolyl and sugar derivatives.
    El-Sayed WA; Ali OM; Zyada RA; Mohamed AA; Abdel-Rahman AA
    Acta Pol Pharm; 2012; 69(3):439-47. PubMed ID: 22594258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors.
    Bugge S; Moen IU; Sylte KO; Sundby E; Hoff BH
    Eur J Med Chem; 2015 Apr; 94():175-94. PubMed ID: 25768701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological study of 3-(phenylsulfonyl)thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines as potent and selective serotonin 5-HT6 receptor antagonists.
    Ivachtchenko AV; Golovina ES; Kadieva MG; Koryakova AG; Kovalenko SM; Mitkin OD; Okun IM; Ravnyeyko IM; Tkachenko SE; Zaremba OV
    Bioorg Med Chem; 2010 Jul; 18(14):5282-90. PubMed ID: 20541425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.